Again in phase III, no significant difference between the two treatment arms was found, even though PFS was significantly longer in patients who received dacomitinib 68 <a href=http://accutane.buzz>ipledge login accutane</a>
Comment Guidelines:
- Please keep comments and questions short and to the point.
- Try to keep things civil and overall try to keep the conversations respectful.
- No four letter words.
- No missionizing.
- Site moderators reserve the right to delete your comments if they do not follow the guidlines or are off-topic.
Comments:
There are no Comments to show. Comment and start the discussion.